Treeline Biosciences
Developing novel therapeutics for challenging diseases using advanced biological insights.
About
Treeline Biosciences is a biotechnology company focused on discovering and developing new medicines for diseases with high unmet medical needs. They leverage a deep understanding of biological pathways and cutting-edge research to create innovative therapeutic candidates. Teams look it up for Biotech, MedTech, Drug Discovery.
Frequently asked
What does Treeline Biosciences do?
Treeline Biosciences is a Biotech company that offers Services. Teams look it up for MedTech, Drug Discovery, Clinical Trials. It is based in Cambridge, United States and was founded in 2019. Public records show $200M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Treeline Biosciences raised?
Treeline Biosciences has raised a total of $200M in funding. The most recent round on record is Series B.
Where is Treeline Biosciences headquartered?
Treeline Biosciences is headquartered in Cambridge, United States.
When was Treeline Biosciences founded?
Treeline Biosciences was founded in 2019.
What industry does Treeline Biosciences operate in?
Treeline Biosciences operates in Biotech, MedTech, Drug Discovery, Clinical Trials, Therapeutics.
What is Treeline Biosciences's current status?
Treeline Biosciences's current operating status is: Inactive.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.